|
| |
| | | | 1 | | | DO1.PCCNTR.1617303 ContractData Container |
| | | 1.1 | | | | | | | | | | 97,172,000.00 | 0.00 | 0.00 | 0.00 | 93,192,000.00 | 97,172,000.00 |
|
| | | | | | | 6 | | 51111805 - Acetato de gos(...)51111805 - Acetato de goserelina |
| 2.3.4.1.01 | Atezolizumab 1200 Mg / 20 Ml (60Mg/Ml) | 80 | UD | 384,000 | 382,000 | 30,560,000.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 30,720,000.00 | 30,560,000.00 | |
|
| | | | | | | 13 | | 51131802 - Factores antih(...)51131802 - Factores antihemofílicos o globulinas |
| 2.3.4.1.01 | Factor IX 500 UI/vial | 500 | UD | 9,000 | 9,000 | 4,500,000.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 4,500,000.00 | 4,500,000.00 | |
|
| | | | | | | 14 | | 51131802 - Factores antih(...)51131802 - Factores antihemofílicos o globulinas |
| 2.3.4.1.01 | Factor VIII De Coagulacion Humana 500UI / 2.5Ml | 2,300 | UD | 4,500 | 6,300 | 14,490,000.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 10,350,000.00 | 14,490,000.00 | |
|
| | | | | | | 23 | | 2.3.4.1.01 | Obinutuzumab 1000 Mg / 40 Ml | 60 | UD | 99,800 | 99,800 | 5,988,000.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 5,988,000.00 | 5,988,000.00 | |
|
| | | | | | | 27 | | 2.3.4.1.01 | Pertuzumab 420 Mg / 14 Ml | 24 | UD | 197,000 | 197,000 | 4,728,000.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 4,728,000.00 | 4,728,000.00 | |
|
| | | | | | | 33 | | 51201569 - Atlizumab o to(...)51201569 - Atlizumab o tocilizumab |
| 2.3.4.1.01 | Tocilizumab 80 Mg / 4 Ml | 300 | UD | 6,900 | 6,900 | 2,070,000.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 2,070,000.00 | 2,070,000.00 | |
|
| | | | | | | 34 | | 2.3.4.1.01 | Trastuzumab 600 Mg / 5 Ml | 60 | UD | 63,000 | 63,000 | 3,780,000.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 3,780,000.00 | 3,780,000.00 | |
|
| | | | | | | 42 | | 2.3.4.1.01 | Cladribina 10 Mg | 160 | UD | 194,100 | 194,100 | 31,056,000.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 31,056,000.00 | 31,056,000.00 | |
|
|
| | | |
| | | |
|